AHCO vs NEOG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AHCO Captures Institutional Edge (3โ1 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Options & Structure while NEOG counters with relative strength in Momentum & Technical. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus NEOG at 35.2x Forward P/E and -0.8% operating margin (+6.5% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against NEOG sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AHCO Revenue | NEOG Revenue | AHCO Op. Margin | NEOG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $530M | $410M | 5.5% | 16.4% | NEOG |
| FY2020 | $1.06B | $420M | 6.8% | 16.1% | NEOG |
| FY2021 | $2.45B | $470M | 9.2% | 15.8% | NEOG |
| FY2022 | $2.97B | $530M | 6.4% | 11.1% | NEOG |
| FY2023 | $3.20B | $820M | -18.7% | 4.6% | NEOG |
| FY2024 | $3.26B | $920M | 8.1% | 6.3% | AHCO |
| FY2025 | $3.24B | $890M | 2.8% | -118.6% | AHCO |
| FY2026 | N/A | $870M | N/A | -2.5% | NEOG |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AHCO | NEOG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $989.8M | $2.4B | Larger Scale | NEOG |
| Trailing P/E Ratio Valuation | 7.8x | 16.0x | Lower Multiple | AHCO |
| Forward P/E Ratio Valuation | 7.8x | 35.2x | Lower Multiple | AHCO |
| Revenue Growth (YoY) Growth | +10.9% | +6.5% | Higher Growth | AHCO |
| Operating Margin (TTM) Profitability | 3.8% | -0.8% | Higher Margin | AHCO |
| Net Profit Margin Profitability | -11.8% | -6.3% | Higher Margin | NEOG |
| Return on Equity (ROE) Capital Efficiency | -28.4% | -2.7% | Higher ROE | NEOG |
| 52-Week Range Position Momentum | 24% ($5โ$13) | 58% ($5โ$14) | Stronger Trend | NEOG |
| Beta / 30D Volatility Risk Regime | 0.17ฮฒ ยท 67% Vol | 1.35ฮฒ ยท 41% Vol | Lower Realized Risk | NEOG |
| Unified Institutional Score Composite Signal | 45.2 / 100 (HOLD) | 45.2 / 100 (HOLD) | Higher Composite | Tie |